✦ LIBER ✦

BENDAMUSTINE AND CETUXIMAB IN COMBINATION AS ALTERNATIVE THERAPEUTIC OPTION FOR RECURRENT HEAD AND NECK CANCER

✍ Scribed by B. Tschechne; J. Borghardt; I. Wildfang; D. Schroder; H. Niebuhr; H. Zakaria; S. Fanaei; S. Luft; W.O. Jordan

Book ID: 119518680
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 461 KB
Volume: 98
Category: Article
ISSN: 0167-8140
DOI: 10.1016/s0167-8140(11)70060-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of weekly paclitaxel

Efficacy and safety of weekly paclitaxel combined with cetuximab in the treatment of pretreated recurrent/metastatic head and neck cancer patients

✍ Jiménez, Begoña; Trigo, José M.; Pajares, Bella I.; Sáez, Maria I.; Quero, Crist 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 509 KB

PCN86 COST-EFFECTIVENESS OF CETUXIMAB CO

PCN86 COST-EFFECTIVENESS OF CETUXIMAB COMBINED WITH RADIOTHERAPY FOR PATIENTS WITH LOCALLY ADVANCED HEAD AND NECK CANCER IN TAIWAN

✍ AL Chan; HW Leung; SJ Lin 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

8550 Clinical experience with Cetuximab

8550 Clinical experience with Cetuximab and Paclitaxel combination in metastatic/recurrent squamous cell cancer carcinoma of the head and neck (SCCHN) – retrospective analysis of a single institution

✍ de Corcuera, I. Diaz; Serrano, C.; Perez, J.; Quispe, I.; Arguis, M.; Muñoz, E.; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Phase I/II study of S-1 combined with ca

Phase I/II study of S-1 combined with carboplatin in recurrent and/or metastatic head and neck cancer as outpatient chemotherapy

✍ Akihito Watanabe; Masanobu Taniguchi; Tetsuro Yamashita; Michihiro Ueda; Tatsuya 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 2 views

## Abstract ## Background. The aims of this study were to determine the recommended dose (RD) in combination chemotherapy of S‐1 and carboplatin in recurrent and/or metastatic head and neck cancer (phase I) and to examine response rate and toxicities at RD (phase II). ## Methods. S‐1 was given o

Liposome-based Nanoprobe With Antibody C

Liposome-based Nanoprobe With Antibody Conjugation Combined With MRI Contrast Encapsulation as a Potential Diagnostic and Therapeutic Agent for Human Head-and-Neck Cancer Cells

✍ Kuo, Y.; Hung, C.; Raghavan, S.R.; D'Souza, W.D. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 51 KB

An Economic Evaluation of Cetuximab Comb

An Economic Evaluation of Cetuximab Combined with Radiotherapy for Patients with Locally Advanced Head and Neck Cancer in Belgium, France, Italy, Switzerland, and the United Kingdom

✍ Ben Brown; Alexander Diamantopoulos; Jacques Bernier; Patrick Schöffski; Klaus H 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 168 KB